CRVO Stock Analysis: Buy, Sell, or Hold?
CRVO - CervoMed Inc. Common Stock
$3.71
0.02 (0.54%)
▲
5d:
-4.38%
30d:
-7.25%
90d:
-27.96%
HOLD
MODERATE Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 11, 2026
8d
Get Alerted When CRVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CRVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CRVO is currently trading at $3.71, which is considered oversold relative to its 30-day fair value range of $3.76 to $4.03.
Technical Outlook: Technically, CRVO is in a strong downtrend. The price is currently testing key support at $3.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRVO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.14 (+496.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRVO is in a strong downtrend. The price is currently testing key support at $3.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRVO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.14 (+496.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.76 -
$4.03
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 496.8% below Wall St target ($22.14)
Trading Range Analysis
30-Day Trading Range
$3.76 -
$4.03
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.61
Resistance Level
$4.25
Current Trend
Strong Downtrend
Technical data as of
May 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.19
Wall Street Target
$22.14
(+496.8%)
Revenue Growth (YoY)
-99.6%
Share & Embed Analysis
Last updated: May 02, 2026 5:29 PM ET
Data refreshes hourly during market hours. Next update: 6:29 PM
Data refreshes hourly during market hours. Next update: 6:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVO showing a specific setup today?
Insider Activity (6 Months)
18
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
William Robert Elder
BUY
2500 shares
2025-11-18
Matthew Winton
BUY
1500 shares
2025-11-18
John J Alam
BUY
10807 shares
2025-11-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 60 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 47 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 52 HOLD |
